By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally agreed that while VB has advantages in liquidity and expense ratio, ISCB's broader diversification and potential for higher growth make it a more 'honest' small-cap product. However, they also highlighted significant risks, including higher turnover, tracking error, and sensitivity to interest rates and market liquidity.
Risk: Exposure to 'zombie' firms in ISCB and higher turnover leading to potential tracking error and reconstitution drag.
Opportunity: ISCB's broader diversification and potential for higher growth in certain market cycles.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
iShares Morningstar Small-Cap ETF (NYSEMKT:ISCB) and Vanguard Small-Cap ETF (NYSEMKT:VB) offer nearly identical low-cost exposure to small-cap stocks, though ISCB provides slightly broader diversification and a marginally higher yield.
Both funds target the small-cap segment of the U.S. market, aiming to capture the growth potential of smaller companies. While they share similar goals and price points, differences in liquidity and index methodology set these two long-running options for diversified portfolios apart.
| Metric | VB | ISCB | |---|---|---| | Issuer | Vanguard | iShares | | Expense ratio | 0.03% | 0.04% | | 1-yr return (as of June 23, 2026) | 28.00% | 29.90% | | Dividend yield | 1.19% | 1.27% | | Beta | 1.03 | 1.04 | | AUM | $182.7 billion | $277.7 million |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
ISCB’s expense ratio is 0.04%, slightly higher than VB’s 0.03%. Investors in the iShares fund receive a marginally higher payout, with a 1.27% yield compared to 1.19% for the Vanguard fund.
| Metric | VB | ISCB | |---|---|---| | Max drawdown (5 yr) | (28.20%) | (29.90%) | | Growth of $1,000 over 5 years (total return) | $1,402 | $1,332 |
The iShares fund targets small companies with a portfolio consisting of 1,544 holdings. Sector allocations include industrials at 18%, technology at 16%, and financial services at 16%. Its largest positions include Sterling Infrastructure (NASDAQ:STRL) at 0.45%, Okta (NASDAQ:OKTA) at 0.31%, and Roku (NASDAQ:ROKU) at 0.28%. This fund launched in 2004 and has paid $0.95 per share over the trailing 12 months.
In contrast, the Vanguard fund follows the CRSP U.S. Small Cap Index and holds 1,357 stocks. It maintains a higher tilt toward industrials at 21%, with technology at 19% and financial services at 12%. Top holdings include Flex (NASDAQ:FLEX) at 0.69%, Astera Labs (NASDAQ:ALAB) at 0.62%, and Ciena (NYSE:CIEN) at 0.51%. Also launched in 2004, the fund has a trailing-12-month dividend of $3.50 per share.
For more guidance on ETF investing, check out the full guide at this link.
These two funds are both excellent options for investors looking for small-cap stocks in the United States. They both have low expense ratios, similar dividend yields, and major name brands backing the ETFs. That said, there are a couple of reasons why I would lean ever-so-slightly toward choosing VB.
First, VB’s past returns have sailed past ISCB’s. Though the ETFs are fairly similar, VB has generated annualized total returns of 10% since 2004, whereas ISCB only reached 8.9%. Not a major difference, but enough to matter. Second, VB is 600 times larger than ISCB, so its massive asset base makes it much less susceptible to liquidation risk.
Lastly, VB’s relative outperformance comes with a similar beta and a slightly smaller five-year drawdown, delivering superior returns while providing a smoother ride for investors. Realistically, I don’t think investors can go wrong with either, but VB offers a few minor upgrades that have me picking it over ISCB.
Before you buy stock in iShares Trust - iShares Morningstar Small-Cap ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $387,428! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,221,398!
Now, it’s worth noting Stock Advisor’s total average return is 895% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 26, 2026. *
Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Ciena, Okta, Roku, and Sterling Infrastructure. The Motley Fool recommends Astera Labs and Flex. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"True edge in small-cap investing comes from index exposure and factor cycles, not tiny expense ratios or AUM; ISCB could outperform VB in rotation regimes despite VB’s size!"
Opening take: The VB vs ISCB comparison highlights VB's scale and marginally lower expense ratio as edge-takers, but the article glosses over deeper risk and nuance. In small caps, tracking error, index methodology, and stressed-market liquidity often matter more than a 0.01% fee delta. ISCB’s broader 1,544-holding lineup may reduce idiosyncratic risk and better capture cross-sectional winners, a subtle but meaningful source of alpha in certain cycles. The piece also omits real-world frictions like reconstitution schedules, tax efficiency, and bid/ask spreads, which can erode apparent returns in volatile periods for thinly traded assets.
The strongest counter is that ISCB’s broader diversification could outperform VB during factor rotations toward growth or quality small-caps, despite the fee gap. Also, a few lagging or overvalued names in VB’s index could bite more in a downturn, challenging the perceived scale advantage.
"VB functions more like a mid-cap fund due to its index methodology, making ISCB the better choice for investors specifically seeking pure, smaller-cap exposure."
While the article champions VB for its liquidity and historical performance, investors should be wary of 'index drift' and structural differences. VB tracks the CRSP U.S. Small Cap Index, which has historically leaned toward the larger end of the small-cap spectrum, effectively becoming a 'mid-cap lite' fund. ISCB, by tracking the broader Morningstar Small Cap Index, captures a more granular slice of the market. The massive AUM gap is a red herring for long-term retail holders; ISCB’s $277 million is plenty to prevent liquidation. If you want true small-cap beta—higher growth potential and higher volatility—ISCB is arguably the more 'honest' product, despite the lower historical returns.
If the goal is minimizing tracking error and slippage in a large portfolio, VB's massive liquidity and tighter bid-ask spreads make it the objectively superior institutional vehicle regardless of index nuance.
"VB's liquidity and cost advantage are structural and real, but the 1.1% annualized return gap over 20 years is too small to attribute to manager quality and warrants index-level analysis before declaring a winner."
The article's AUM figures are inverted—VB at $182.7B vs ISCB at $277.7M creates a 600x liquidity gap that's real and material. But the 5-year performance gap (VB $1,402 vs ISCB $1,332 per $1k invested) is modest and could reflect index methodology rather than manager skill. ISCB's Morningstar Small-Cap Index uses different selection criteria than VB's CRSP index, so comparing returns without isolating which index drove outperformance is incomplete. The article also omits tracking error data and whether VB's outperformance persists in different market regimes. For most retail investors, the liquidity advantage and lower expense ratio favor VB, but the performance edge isn't as decisive as presented.
ISCB's narrower AUM could be a feature, not a bug—smaller funds sometimes outperform because they're less constrained by index rebalancing drag and can hold higher-conviction positions; VB's 600x size may actually create hidden trading costs that offset its fee advantage.
"VB's edge is overstated because ISCB's broader holdings and recent returns offset the modest AUM and historical return gaps the article emphasizes."
The article's slight lean toward VB over ISCB rests on historical returns and AUM scale, yet ignores that ISCB's 1,544 holdings deliver meaningfully broader diversification than VB's 1,357, while posting a stronger 29.9% trailing 1-year return. Both ETFs launched in 2004 with near-identical costs, but the piece downplays how small-cap performance remains sensitive to rate cuts and credit conditions that neither index directly controls. Liquidity differences matter less for long-term holders than tracking methodology and sector tilts (ISCB heavier in financials, lighter in industrials).
VB's 600x AUM advantage could still dominate if ISCB faces redemption pressure during a prolonged small-cap drawdown, making the liquidity edge more durable than current diversification metrics suggest.
"In small-cap ETFs, diversification breadth can backfire in turbulent periods because higher turnover and more reconstitution create tracking errors that can erase the tiny fee edge VB has, so execution costs and liquidity dynamics matter more than the 0.01% expense delta."
Claude's focus on AUM and liquidity omission misses a bigger friction: diversification breadth can backfire in turbulent periods. ISCB's 1,544 holdings imply higher turnover, more reconstitution events, and potentially larger tracking error when market liquidity dries up; that can erode the tiny fee edge vs VB. In practice, the cost gap that matters in small caps is not expense ratio but actual execution costs, creation/redemption fees, and bid-ask spread sensitivity during drawdowns.
"ISCB's broader index inclusion likely increases exposure to low-quality, interest-sensitive firms that underperform in current credit conditions."
Gemini’s claim that ISCB is an 'honest' small-cap product is dangerous. By prioritizing a purer micro-cap exposure, ISCB inherently increases exposure to 'zombie' firms—companies unable to cover interest expenses from operating income. In a higher-for-longer rate environment, this isn't just 'higher volatility'; it's a structural drag on returns. VB’s 'mid-cap lite' drift is actually a defensive quality tilt that likely explains its superior risk-adjusted performance, which the panel is mischaracterizing as mere index methodology.
"Rate sensitivity and liquidity stress matter more than index purity; ISCB's micro-cap tilt is a feature until rates spike or redemptions hit."
Gemini's 'zombie firm' framing is speculative—no data on ISCB's actual interest coverage distribution. But the rate-sensitivity angle is real: ISCB's micro-cap tilt does amplify duration risk in a 5%+ rate environment. However, ChatGPT overstates reconstitution drag; Morningstar's index actually rebalances less frequently than CRSP. The real friction nobody quantified: bid-ask spreads during stress. ISCB's $277M AUM means wider spreads on exit, which could dwarf the 0.04% fee gap in a 20% drawdown.
"ISCB micro-cap holdings tie rate risk to credit-driven liquidity spikes that exceed AUM effects alone."
Claude's rate-sensitivity point directly amplifies Gemini's zombie-firm exposure in ISCB: micro-caps unable to cover interest from operations face acute refinancing pressure above 5%, likely forcing sales that spike bid-ask spreads far beyond the $277M AUM baseline. This interaction creates a hidden liquidity trap during credit crunches that neither panelist quantified against VB's more defensive tilt.
The panelists generally agreed that while VB has advantages in liquidity and expense ratio, ISCB's broader diversification and potential for higher growth make it a more 'honest' small-cap product. However, they also highlighted significant risks, including higher turnover, tracking error, and sensitivity to interest rates and market liquidity.
ISCB's broader diversification and potential for higher growth in certain market cycles.
Exposure to 'zombie' firms in ISCB and higher turnover leading to potential tracking error and reconstitution drag.